Drew’s Journey with Noonan Syndrome
This month in the Year of Discovery, FDNA spotlights syndromes categorized as RASopathies. Every case uploaded in March will be Read more
How data warehouses can speed identification of rare diseases
Dekel Gelbman, CEO of FDNA, was featured in Health Data Management discussing the value for hospitals of using clinical data Read more
FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery
FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to Read more
What to Do and See at ACMG 2017 in Phoenix, AZ
Annual Clinical Genetics Meeting (ACMG 2017) Phoenix Convention Center, Phoenix, Arizona March 21-25, 2017 Phoenix, Arizona – With ACMG just over Read more
Phenotyping Adds a Face to Complement Genetics
Dr. Robert L. Stevenson of Labcompare discusses the use of phenotyping and facial analysis as an important supplement to molecular testing. Read more
Pinpointing Rare Diseases with Facial Analysis and Phenotyping Technology
Dekel Gelbman, CEO of FDNA, was featured in Medical Device and Diagnostics Industry, discussing the value of facial analysis technology Read more
Phenotyping technologies save on costs and improve rare disease workflows
Dekel Gelbman, CEO of FDNA, was featured in Becker’s Hospital Review, discussing the value of phenotyping to hospitals involved in Read more